Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,166.00
Bid: 12,166.00
Ask: 12,168.00
Change: -24.00 (-0.20%)
Spread: 2.00 (0.016%)
Open: 12,304.00
High: 12,356.00
Low: 12,088.00
Prev. Close: 12,190.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TOP NEWS: Japan approves Moderna and AstraZeneca vaccines

Fri, 21st May 2021 08:17

(Alliance News) - Japan formally approved the Covid-19 vaccines of Moderna Inc and AstraZeneca PLC on Friday, but the latter will not be used immediately because of lingering concern over very rare blood clots.

The decision comes just over two months before the pandemic-postponed Olympics, with growing disquiet in Japan about the country's comparatively slow vaccine rollout.

Nine regions including Tokyo are already under a virus state of emergency, with the measure now being expanded to Okinawa in the south.

Until now, only the vaccine from Pfizer Inc and BioNTech SE was available in Japan, after being approved in February, and so far just 2% of the country's 125 million residents are fully vaccinated.

In a statement, the health ministry said the two additional formulas had been approved.

But a spokesman said discussion would continue on use of the AstraZeneca vaccine "while monitoring the situation in other countries".

Only medical workers and the elderly are so far eligible for vaccines, with no timeframe yet for expanding the rollout.

Two mass vaccination centres operated by the military will open next week in Tokyo and Osaka to administer the two-shot Moderna vaccine, initially to the over-65s.

There is no timeline yet for use of the AstraZeneca jab, which some countries have restricted or dropped from their vaccine campaigns over rare blood clot concerns, even though experts say the benefits outweigh the risks.

AstraZeneca separately said its vaccine, called Vaxzevria, was approved for emergency use by the Japanese Ministry of Health, Labour & Welfare. Production of the vaccine in Japan is already underway, it said, and the first doses are expected to be available in the coming weeks.

Moderna's chief executive told the Nikkei newspaper on Friday that it was considering manufacturing the vaccine in Asia, possibly in Japan.

International Olympic Committee chief Thomas Bach said this week that at least three-quarters of athletes and team members staying at Tokyo's Olympic village will be vaccinated before the Games, which open on July 23.

Organisers insist the event can be held safely this summer, although public opinion remains largely opposed as infections surge in Japan.

Nine regions including Tokyo are currently under a virus state of emergency that runs until May 31. But recent reports have suggested the measure could be extended for a second time.

And on Friday, the southern island region of Okinawa will be added to the areas under the emergency measures for a period running from Sunday until June 20.

Japan has seen a relatively small coronavirus outbreak, with around 12,000 deaths overall, but a recent surge in infections has put hospitals under strain, medics say.

Japan has agreements with drug firms to provide enough vaccines for its entire population, including Moderna doses for 25 million people, Pfizer for 97 million people and AstraZeneca doses sufficient to vaccinate 60 million people.

source: AFP

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
15 Dec 2023 17:14

London stocks log weekly gains as cenbank fest ends

FTSE 100 down 1.0%, FTSE 250 off -0.3%

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
13 Dec 2023 17:07

UK's FTSE 100 rises as pound slips on GDP data; awaits Fed rate decision

UK economy shrinks by 0.3% in October

*

Read more
12 Dec 2023 16:00

London close: Stocks slip as investors digest US inflation

(Sharecast News) - London's markets finished in the red on Tuesday, as investors digested a slight decrease in consumer inflation in the US, while the UK's unemployment figures remained stable.

Read more
12 Dec 2023 12:07

London midday: FTSE still firmer ahead of US inflation print

(Sharecast News) - London's markets remained relatively stable by midday on Tuesday, with the top-flight index still in the green after fresh jobs data showed a slowdown in wage growth.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:53

LONDON MARKET OPEN: FTSE 100 opens higher ahead of US CPI

(Alliance News) - Stock prices in London opened higher on Tuesday, as investors digest the latest UK unemployment data, before turning their eyes to US inflation this afternoon.

Read more
12 Dec 2023 08:37

AstraZeneca acquires vaccine developer Icosavax for USD1.1 billion

(Alliance News) - AstraZeneca PLC confirmed on Tuesday that it will buy Icosavax Inc, boosting its vaccine portfolio with an "innovative" treatment for respiratory viruses.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more
12 Dec 2023 07:16

AstraZeneca to buy US vaccine maker Icosavax for up to $1.1bn

(Sharecast News) - AstraZeneca said on Tuesday that it has agreed to buy Icosavax - a US-based clinical-stage biopharmaceutical company - for up to $1.1bn.

Read more
12 Dec 2023 02:00

UK companies pause China investment decisions as economy slows, survey shows

BEIJING, Dec 12 (Reuters) - A slowdown in both the Chinese and global economies is the biggest issue affecting British firms in the world's second-largest economy, beating geopolitical concerns and market access barriers, according to the British Chamber of Commerce in China.

Read more
11 Dec 2023 08:15

AstraZeneca says danicopan tests well as blood disorder treatment

(Alliance News) - AstraZeneca PLC on Monday reported "positive results" from a test of danicopan for the treatment of paroxysmal nocturnal haemoglobinuria, or PNH, a rare and severe blood disorder.

Read more
5 Dec 2023 10:02

LONDON BROKER RATINGS: Goldman lifts Landsec and British Land

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
1 Dec 2023 08:52

LONDON MARKET OPEN: Miners give FTSE 100 boost thanks to China PMI

(Alliance News) - Stock prices in London opened higher on Friday, with the FTSE 100 boosted by mining stocks.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.